SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is rallying as community sentiment shifts, driven by a significant revenue beat and a massive expansion in its backlog that signals robust demand for AI infrastructure. While bulls are touting the potential for a short squeeze and long-term scaling, bears remain focused on the company's substantial debt load, heavy capital expenditures, and ongoing operational losses.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors react to a new strategic tender win with the Israeli Ministry of Defense, fueling optimism ahead of upcoming quarterly earnings. The community is actively debating the stock's high short interest and technical setup, with many shareholders anticipating a potential squeeze driven by institutional buying and a robust pipeline of defense contracts.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing intense community engagement following a major earnings beat and significantly higher-than-expected revenue guidance for the coming fiscal year, which investors are highlighting as a strong signal of persistent AI infrastructure demand. While the stock's price action remains volatile, shareholders are actively discussing a potential short squeeze and institutional re-rating, contrasting the company's surging profitability and record order backlog against ongoing skepticism surrounding its management and previous regulatory headlines.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing downward pressure following a competitor's weak fiscal report and a J.P. Morgan downgrade that cited concerns over a prolonged turnaround in China. While the community is divided between those viewing the price decline as a long-term value opportunity and those frustrated by the stock's stagnant performance, discussions remain heavily focused on whether current leadership can effectively execute its strategic reset.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors react to a strong quarterly report and optimistic guidance, which are being viewed as indicators of sustained demand for optical connectivity in AI data centers. Community discussion is focused on the company's ability to capitalize on market constraints for laser components, with many participants treating recent price pullbacks as buying opportunities while debating the broader momentum within the optics sector.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is actively trading around the $100 level, drawing intense focus from the community as investors weigh the impact of recent Bitcoin treasury activity and corporate dilution against potential regulatory catalysts. Market participants remain sharply divided, with bulls looking for a breakout driven by institutional momentum while bears continue to highlight concerns over debt obligations and consistent share issuance.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is seeing intense community focus as investors monitor the company's shift toward commercial revenue execution, fueled by recent strategic semiconductor acquisitions and expansion into photonic quantum systems. Despite lingering volatility and debate over short interest levels, bulls are optimistic that upcoming earnings and new commercial partnerships will serve as catalysts for a major breakout.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as the market digests a significant expansion of its production capacity, which the community views as a critical step toward securing large-scale aerospace and defense contracts. Traders are actively debating the stock's short-term volatility and potential for a squeeze, while long-term supporters emphasize the company's role as a vital infrastructure play within the metal additive manufacturing sector.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is trending as traders debate its potential for a massive breakout, fueled by optimism surrounding its high volume and ongoing token staking activity. While some community members are bullish on the project's recent feature updates and long-term utility, others remain skeptical, pointing to historical volatility and cautioning against potential short-term pullbacks.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is trending as investors weigh its impressive global revenue growth and premium brand positioning against concerns regarding cooling sales momentum in the Americas and potential competitive pressure. The community is actively debating the stock's rich valuation and leadership transitions, with many analysts focusing on whether the company can maintain its long-term growth story as it competes with established giants in a challenging consumer environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SELLAS Life Sciences is trending as investors await the final Phase 3 trial survival event, with community sentiment fueled by the significant extension of patient survival and high expectations for regulatory milestones. Discussion is primarily focused on the company's strong cash position, progress on clinical assets, and the strategic quiet period preceding potential trial results or corporate partnerships.

The drop appears driven by sympathy selling after sharp declines in other biotech stocks (TENX, SION) following failed trials, which has weighed on sentiment for high-risk clinical-stage names. Additionally, traders are awaiting the upcoming Q2 earnings report and potential update on the REGAL trial's 80th event, with no positive company-specific catalyst emerging today.

SLS Stock Flat After-Hours Despite Narrower Per-Share Q2 Loss — Investors Eye End Of GPS Quiet Period

Equity

The biotech, focused on novel cancer therapies, reported a net loss of $9.6 million, or $0.05 per share, for the quarter ended June 30. 

S&P 500, Nasdaq, Dow Futures Mixed As CPI Countdown Begins: Why INTC, SLS, SPCX, RKLB, ASTS, RIOT, FRMI Stocks Are In Focus

Retail sentiment on Stocktwits has declined to ‘neutral’ on SPY and ‘extremely bearish’ on QQQ.


SLS Stock Rebounds Premarket After Worst Day In 3 Weeks — Retail Awaits ‘Very Special’ Earnings Update 

Wall Street expects no quarterly revenue and a GAAP loss of $0.04 per share, narrowing from $0.05 previously.

Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive

IBRX and SLS align with Big Pharma’s cancer push, fueling retail partnership and buyout speculation.

Nasdaq, S&P 500, Dow Futures Extend Gains After Hot Rally As Big Tech Earnings Deliver:  PLTR, GME, SNAP, SLS In Focus

U.S. futures climbed higher on growing optimism stoked by standout earnings from top American companies, looking past geopolitical uncertainty. 

SLS Stock Logs Best Day In Over 2 Weeks: Citigroup Builds Nearly $5M Stake Ahead Of Key AML Trial Trigger 

Vontobel cut its holding by 16% but retained SLS shares worth $2.17 million.

SLS Stock Eyes Green Start To August After Nearly $6M In Fresh Institutional Buying: Retail Stays Bearish 

Opus Capital held 385,604 shares worth about $5.69 million after increasing its position by 11.3%.

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

A potential AstraZeneca-Bristol Myers deal worth $400 billion would create one of the world’s largest drugmakers and combine major cancer franchises.

SLS Stock In Spotlight After Vanguard Capital Discloses 5.19% Stake – Retail Calls It ‘Huge Vote Of Conviction’ As AML Trial Readout Nears

A new Schedule 13G filing showed Vanguard Capital Management owned 9.67 million SLS shares as of June 30, 2026.

SLS Stock Turns Green After 3-Day Rout: Five Investors Add Shares As Key AML Trial Nears Final Trigger 

New York State Common Retirement Fund boosted its holding by 70%, while Commonwealth and Axxcess each raised stakes by about 17%.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Bullish Sentiment

$TMDX

$SLS

Which of these trending stocks are you most tempted to buy - $ON, $TMDX, $SLS, or $BE?

Stocktwits

ON Semiconductor Corp.

Transmedics Group Inc

Bloom Energy Corp - Ordinary Shares - Class A

Which of these trending stocks are you most tempted to buy - 

Stocktwits Polls

Investors are closely monitoring the Phase 3 REGAL trial data, as the elusive 80th event trigger remains pending and vital for final analysis.

Traders are highlighting that management has refrained from using the company's at-the-market offering, viewing the maintained cash runway as a bullish sign of strength.

Market participants are noting that a significant portion of outstanding warrants have been cleared, drastically reducing the potential for share dilution.

Optimism surrounds the data-backed potential for immunotherapy, with patients showing life-prolonging results and ongoing research into new oncology indications.

Speculation remains high among longs that the company's quiet period and pending trial milestones suggest potential strategic partnership or acquisition discussions.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLSSELLAS Life Sciences Group Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SLS News